We are live on ! Find out more
GMED icon

Globus Medical

450 hedge funds and large institutions have $7.72B invested in Globus Medical in 2024 Q2 according to their latest regulatory filings, with 69 funds opening new positions, 136 increasing their positions, 167 reducing their positions, and 55 closing their positions.

New
Increased
Maintained
Reduced
Closed

416% more call options, than puts

Call options by funds: $16.1M | Put options by funds: $3.12M

38% more funds holding in top 10

Funds holding in top 10: 1622 (+6)

27% more capital invested

Capital invested by funds: $6.08B → $7.72B (+$1.64B)

25% more first-time investments, than exits

New positions opened: 69 | Existing positions closed: 55

3% more funds holding

Funds holding: 439450 (+11)

0.32% less ownership

Funds ownership: 100.41%100.09% (-0.32%)

19% less repeat investments, than reductions

Existing positions increased: 136 | Existing positions reduced: 167

Holders
450
Holders Change
+11
Holders Change %
+2.51%
% of All Funds
6.5%
Holding in Top 10
22
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+37.5%
% of All Funds
0.32%
New
69
Increased
136
Reduced
167
Closed
55
Calls
$16.1M
Puts
$3.12M
Net Calls
+$13M
Net Calls Change
+$3.82M
Name Holding Trade Value Shares
Change
Change in
Stake
MAM
201
Madison Asset Management
Wisconsin
$1.38M -$1.11M -18,505 -48%
CIA
202
Capital Impact Advisors
Massachusetts
$1.36M -$483K -8,088 -29%
MC
203
Montag & Caldwell
Georgia
$1.33M +$271K +4,528 +30%
AI
204
Atom Investors
Texas
$1.32M -$1.37M -22,940 -54%
TAM
205
Tealwood Asset Management
Minnesota
$1.3M -$358 -6 -0%
BCM
206
Bridgeway Capital Management
Texas
$1.28M +$1.12M +18,700 New
Bank of Montreal
207
Bank of Montreal
Ontario, Canada
$1.28M +$95.9K +1,606 +9%
Susquehanna International Group
208
Susquehanna International Group
Pennsylvania
$1.23M -$1.75M -29,309 -62%
AAS
209
Avantax Advisory Services
Texas
$1.23M +$1.07M +17,915 New
Mariner
210
Mariner
Kansas
$1.21M +$1.73K +29 +0.2%
BNP Paribas Financial Markets
211
BNP Paribas Financial Markets
France
$1.2M -$2.6M -43,597 -71%
HF
212
HRT Financial
New York
$1.2M -$286K -4,792 -21%
Pacer Advisors
213
Pacer Advisors
Pennsylvania
$1.16M -$16K -267 -2%
AFAS
214
Acorn Financial Advisory Services
Virginia
$1.11M -$30.8K -516 -3%
VOYA Investment Management
215
VOYA Investment Management
Georgia
$1.08M -$2.61M -43,707 -73%
QEI
216
QSV Equity Investors
Illinois
$1.08M -$5.44K -91 -0.6%
HPCM
217
Hunter Perkins Capital Management
Illinois
$1.07M +$181K +3,035 +24%
XT
218
XTX Topco
Cayman Islands
$1.06M +$242K +4,043 +35%
LWM
219
LongView Wealth Management
Georgia
$1.05M
AQR Capital Management
220
AQR Capital Management
Connecticut
$1.04M +$13.6K +228 +2%
Prudential Financial
221
Prudential Financial
New Jersey
$1.04M +$186K +3,112 +26%
LCG
222
Lisanti Capital Growth
New York
$1.01M +$884K +14,795 New
MWM
223
Moran Wealth Management
Florida
$999K -$4.28M -71,577 -83%
MYIA
224
Mount Yale Investment Advisors
Colorado
$961K
QC
225
Quadrature Capital
United Kingdom
$960K -$72.4K -1,212 -8%

GMED Hedge Fund Activity: Q2 2024 in Review

450 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Globus Medical (GMED) for Q2 2024, worth a combined $7.72B — up 27% from $6.08B a quarter earlier.

Buyers outnumbered sellers: 69 funds opened new GMED positions and 55 closed out — a net gain of 14 holders — while 136 added to existing stakes and 167 trimmed.

The largest buyer was Select Equity Group, opening a new position worth an estimated $80M. The largest seller was Dimensional Fund Advisors, cutting an estimated $57.1M.

  • 450 institutional investors held Globus Medical (GMED) as of Q2 2024, up from 439 in Q1 2024.
  • Funds reported $7.72B of Globus Medical stock for Q2 2024, up 27% quarter-over-quarter.
  • 69 funds opened new Globus Medical positions in Q2 2024 and 55 closed out, a net change of +14 holders.
  • The largest Globus Medical buyer in Q2 2024 was Select Equity Group, an estimated $80M added.
  • The largest Globus Medical seller in Q2 2024 was Dimensional Fund Advisors, an estimated $57.1M sold.

Based on aggregated 13F filings for Q2 2024.